Education and Training
- Fellow, Infectious Diseases, Duke University School of Medicine, 2008 - 2010
- Resident, Internal Medicine, Duke University School of Medicine, 2005 - 2008
- M.D., Wake Forest University, 2005
Robbins-Juarez, Shelief, Rachel Tobin, Michelle M. Schneider, Adela Rambi G. Cardones, Thomas L. Holland, and Stephen A. Telloni. “Severe Retiform Purpura Associated With COVID-19 Infection.” Annals of Internal Medicine: Clinical Cases 1, no. 2 (April 1, 2022). https://doi.org/10.7326/aimcc.2022.0006.
ACTIV-3/TICO Bamlanivimab Study Group, James D., Jens D. Lundgren, Birgit Grund, Christina E. Barkauskas, Thomas L. Holland, Robert L. Gottlieb, Uriel Sandkovsky, et al. “Responses to a Neutralizing Monoclonal Antibody for Hospitalized Patients With COVID-19 According to Baseline Antibody and Antigen Levels : A Randomized Controlled Trial.” Ann Intern Med 175, no. 2 (February 2022): 234–43. https://doi.org/10.7326/M21-3507.
Lodise, Thomas P., Marc Scheetz, Joseph J. Carreno, Henry Chambers, Vance Fowler, and Thomas L. Holland. “Associations Between Vancomycin Exposure and Acute Kidney Injury Within the Recommended Area Under the Curve Therapeutic Exposure Range Among Patients With Methicillin-Resistant Staphylococcus aureus Bloodstream Infections.” Open Forum Infect Dis 9, no. 2 (February 2022): ofab651. https://doi.org/10.1093/ofid/ofab651.
King, Heather A., Sarah B. Doernberg, Kiran Grover, Julie Miller, Megan Oakes, Tsai-Wei Wang, Molly McFatrich, et al. “Patients' Experiences With Staphylococcus aureus and Gram-Negative Bacterial Bloodstream Infections: Results From Cognitive Interviews to Inform Assessment of Health-Related Quality of Life.” Open Forum Infect Dis 9, no. 2 (February 2022): ofab622. https://doi.org/10.1093/ofid/ofab622.
Scheetz, Marc H., Gwendolyn M. Pais, Thomas P. Lodise, Steven Y. C. Tong, Joshua S. Davis, J Nicholas O’Donnell, Jiajun Liu, et al. “Of Rats and Men: a Translational Model To Understand Vancomycin Pharmacokinetic/Toxicodynamic Relationships.” Antimicrob Agents Chemother 65, no. 10 (September 17, 2021): e0106021. https://doi.org/10.1128/AAC.01060-21.
Carugati, Manuela, S. Aliberti, G. Sotgiu, F. Blasi, A. Gori, R. Menendez, M. Encheva, et al. “Correction to: Bacterial etiology of community-acquired pneumonia in immunocompetent hospitalized patients and appropriateness of empirical treatment recommendations: an international point-prevalence study.” Eur J Clin Microbiol Infect Dis 40, no. 9 (September 2021): 2051. https://doi.org/10.1007/s10096-021-04295-2.
Chambers, Henry F., Scott R. Evans, Robin Patel, Heather R. Cross, Anthony D. Harris, Yohei Doi, Helen W. Boucher, et al. “Antibacterial Resistance Leadership Group 2.0: Back to Business.” Clin Infect Dis 73, no. 4 (August 16, 2021): 730–39. https://doi.org/10.1093/cid/ciab141.
Pericàs, Juan M., Jaume Llopis, Maria Jesús Jiménez-Exposito, Wissam M. Kourany, Benito Almirante, Giampiero Carosi, Emanuele Durante-Mangoni, et al. “Infective Endocarditis in Patients on Chronic Hemodialysis.” J Am Coll Cardiol 77, no. 13 (April 6, 2021): 1629–40. https://doi.org/10.1016/j.jacc.2021.02.014.
ACTIV-3/TICO LY-CoV555 Study Group, James D., Jens D. Lundgren, Birgit Grund, Christina E. Barkauskas, Thomas L. Holland, Robert L. Gottlieb, Uriel Sandkovsky, et al. “A Neutralizing Monoclonal Antibody for Hospitalized Patients with Covid-19.” N Engl J Med 384, no. 10 (March 11, 2021): 905–14. https://doi.org/10.1056/NEJMoa2033130.